While a higher density of cytotoxic CD8+ T cells has been linked to a positive anti-tumor effect (55–59), the CD8+PD-1+ subset of TIL is associated with worse prognosis and therapy outcomes (60–63). This evidence concerns the gene CD8A and neoplasm.